Edition:
United States

PTC Therapeutics Inc (PTCT.OQ)

PTCT.OQ on NASDAQ Stock Exchange Global Select Market

38.85USD
11:19am EDT
Change (% chg)

$0.62 (+1.62%)
Prev Close
$38.23
Open
$38.50
Day's High
$38.95
Day's Low
$38.25
Volume
45,564
Avg. Vol
381,588
52-wk High
$52.95
52-wk Low
$14.88

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Schmertzler

66 2004 Independent Chairman of the Board

Stuart Peltz

58 1998 Chief Executive Officer, Director

Christine Utter

40 2017 Principal Financial Officer and Treasurer

Marcio Souza

39 2017 Chief Operating Officer

Neil Almstead

51 2015 Executive Vice President, Research, Pharmaceutical Operations & Technology